Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma

被引:4
|
作者
Furukawa, Daisuke [1 ,2 ,3 ]
Chijiwa, Tsuyoshi [4 ]
Matsuyama, Masahiro [3 ]
Mukai, Masaya [5 ]
Matsuo, Ei-Ichi [6 ]
Nishimura, Osamu [7 ]
Kawai, Kenji [4 ]
Suemizu, Hiroshi [4 ]
Nakagohri, Toshio [3 ]
Ozawa, Soji [3 ]
Shimada, Kazuaki [8 ]
Hiraoka, Nobuyoshi [1 ,2 ]
Nakamura, Masato [9 ]
机构
[1] Natl Canc Ctr, Res Inst, Div Pathol & Clin Labs, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 1040045, Japan
[3] Tokai Univ, Sch Med, Dept Surg, Isehara, Kanagawa 2591193, Japan
[4] Cent Inst Expt Anim, Kawasaki, Kanagawa 2100821, Japan
[5] Tokai Univ, Hachioji Hosp, Dept Surg, Hachioji, Tokyo 1920032, Japan
[6] Shimadzu Co Ltd, Global Applicat Dev Ctr, Kyoto 6048511, Japan
[7] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan
[8] Natl Canc Ctr, Res Inst, Div Hepatobiliary & Pancreat Surg, Tokyo 1040045, Japan
[9] Tokai Univ, Sch Med, Dept Regenerat Med, Isehara, Kanagawa 2591193, Japan
关键词
zinc finger protein 185; pancreatic ductal carcinoma; prognosis; hematogenous metastasis; subcellular location; LIVER METASTASIS; COLON-CANCER; PAXILLIN; GEMCITABINE; PROTEIN;
D O I
10.3892/ol.2017.6633
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic ductal carcinoma (PDC) is one of the major causes of cancer-associated mortality globally due to its high potential for distant metastasis. To understand hematogenous metastasis, the molecular expression profiles of weak metastatic PDC cell subline BxPC-3 and highly liver-metastatic cell subline LM-BxPC-3 were compared, and zinc finger protein 185 (ZNF185) was identified as a molecule that is upregulated in LM-BxPC-3 cells. The aim of the present study was to evaluate the clinicopathological significance of ZNF185 in PDC. Using immunohistochemistry, ZNF185 expression was investigated in 182 patients with PDC, in association with numerous clinicopathological variables. The expression profile of ZNF185 was also characterized using xenograft models. In contrast to parent BxPC-3 cells in subcutaneous transplanted tumor foci, which only expressed ZNF185 on their plasma membrane (m)ZNF185, LM-BxPC-3 cells in liver-metastatic foci that were formed subsequent to transplantation all expressed cytoplasmic (c)ZNF185. Additionally, 51% of the cells at the periphery of the tumor foci expressed mZNF185. Expression of cZNF185, and of mZNF185 and cZNF185 combined was identified in 93 and 39% of clinical patients with PDC, respectively. Patients with mZNF185-negative and-positive PDC exhibited a median survival time of 30.2 months and 21.3 months, respectively. Multivariate analysis indicated that the expression of mZNF185 is closely associated with a shorter overall survival time. Increased marked venous invasion was more prevalent in patients who were mZNF185-positive, as compared with patients who were mZNF185-negative. These data suggest that the expression of mZNF185 is an independent and unfavorable prognosticator in patients with PDC. The results suggested that the amount and subcellular location of ZNF185 are correlated with the position of the cancer cells expressing it within the nests. Additionally, the subcellular location of ZNF185 may be important to its biological function.
引用
收藏
页码:3633 / 3640
页数:8
相关论文
共 50 条
  • [41] Tumor Budding Is an Independent Adverse Prognostic Factor in Pancreatic Ductal Adenocarcinoma
    O'Connor, Kate
    Li-Chang, Hector H.
    Kalloger, Steven E.
    Peixoto, Renata D.
    Webber, Douglas L.
    Owen, David A.
    Driman, David K.
    Kirsch, Richard
    Serra, Stefano
    Scudamore, Charles H.
    Renouf, Daniel J.
    Schaeffer, David F.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (04) : 472 - 478
  • [42] Tumor Budding Is an Independent Adverse Prognostic Factor in Pancreatic Ductal Adenocarcinoma
    O'Connor, K. M.
    Li-Chang, H. H.
    Kalloger, S. E.
    Webber, D. L.
    Owen, D. A.
    Schaeffer, D. F.
    MODERN PATHOLOGY, 2014, 27 : 452A - 452A
  • [43] GRP78 Expression and Prognostic Significance in Treated and Treatment-Naive Patients with Pancreatic Ductal Carcinoma
    Tong, Yi Tat
    Wang, Hua
    Wei, Dongguang
    Prakash, Laura
    Kim, Michael
    Tzeng, Ching-Wei
    Lee, Jeffrey
    Rashid, Asif
    Wolff, Robert A.
    Maitra, Anirban
    Katz, M. H.
    Wang, Huamin
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 1060 - 1061
  • [44] GRP78 Expression and Prognostic Significance in Treated and Treatment-Naive Patients with Pancreatic Ductal Carcinoma
    Tong, Yi Tat
    Wang, Hua
    Wei, Dongguang
    Prakash, Laura
    Kim, Michael
    Tzeng, Ching-Wei
    Lee, Jeffrey
    Rashid, Asif
    Wolff, Robert A.
    Maitra, Anirban
    Katz, M. H.
    Wang, Huamin
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1060 - 1061
  • [45] NF-Kappa B expression in pancreatic ductal carcinoma
    Tuncel, Deniz
    Bayol, N. Umit
    CUKUROVA MEDICAL JOURNAL, 2019, 44 (02): : 494 - 501
  • [46] PLASMA EXPRESSION OF ENDOTHELIN IN PATIENTS WITH DUCTAL CARCINOMA OF THE BREAST
    Kalles, V.
    Kalogera, E.
    Provatopoulou, X.
    Papapanagiotou, I. K.
    Georgiou, G. P.
    Gounaris, A.
    Zografos, G.
    BREAST, 2013, 22 : S24 - S24
  • [47] Expression of transcription factor E2F-1 in pancreatic ductal carcinoma: An immunohistochemical study
    Yamazaki, K
    Yajima, T
    Nagao, T
    Shinkawa, H
    Kondo, F
    Hanami, K
    Asoh, A
    Sugano, I
    Ishida, Y
    PATHOLOGY RESEARCH AND PRACTICE, 2003, 199 (01) : 23 - 28
  • [48] HDAC1 Expression in Invasive Ductal Carcinoma of the Breast and Its Value as a Good Prognostic Factor
    Eom, Minseob
    Oh, Sung Soo
    Lkhagvadorj, Sayamaa
    Han, Airi
    Park, Kwang Hwa
    KOREAN JOURNAL OF PATHOLOGY, 2012, 46 (04) : 311 - 317
  • [49] Prognostic Significance of Annexin A1 Expression in Pancreatic Ductal Adenocarcinoma
    Chen, Cong-Ying
    Shen, Jia-Qing
    Wang, Feng
    Wan, Rong
    Wang, Xing-Peng
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (09) : 4707 - 4712
  • [50] The Expression Profiles and the Prognostic Study of Galectins Family in Pancreatic Ductal Adenocarcinoma
    Yang, G.
    Tian, H.
    Liu, A. A.
    Chen, D. L.
    Tang, L.
    Shi, L. G.
    Fu, Z. P.
    Liang, X.
    Ji, M.
    Shao, C. H.
    PANCREAS, 2019, 48 (10) : 1553 - 1553